On January 31, 2022, NovAccess Global Inc. (‘NovAccess') entered into a preferred stock redemption agreement (‘Agreement') with TN3, LLC (‘TN3'), Mr. Daniel G. Martin, Irvin Consulting, LLC (‘IC'), and Dr. Dwain Morris-Irvin. Mr. Martin is the company's chairman of the board and owns TN3. Dr. Irvin is the company's chief executive officer and owns IC.

Upon completion of the redemption, Mr. Martin will resign from the NovAccess board and be replaced by Dr. Irvin and John Cassarini.